Lacticaseibacillus casei decrease long-chain fatty acids and most substances in an experimental model of intestinal mucositis-Reference-Cited by-同舟云学术

Lacticaseibacillus casei decrease long-chain fatty acids and most substances in an experimental model of intestinal mucositis

Published:2023 Issue: Volume:38 Page:
ISSN:1678-2674
Container-title:Acta Cirúrgica Brasileira
language:
Short-container-title:Acta Cir. Bras.

Author:

Barbosa Stphannie Jamyla de Araújo¹^ORCID,Silva Amanda Silveira da¹^ORCID,Oliveira Maisie Mitchele Barbosa¹^ORCID,Ribeiro Susana Barbosa¹^ORCID,Medeiros Caroline Addison Carvalho Xavier de¹^ORCID,Ferreira Leandro de Santis¹^ORCID,Pinheiro Francisco Ayrton Senna Domingos¹^ORCID,Sousa Junior Francisco Canindé de¹^ORCID,Martins Agnes Andrade¹^ORCID,Araújo Júnior Raimundo Fernandes de¹^ORCID,Garcia Vinícius Barreto¹^ORCID,Araújo Aurigena Antunes de¹^ORCID

Affiliation:

1. Universidade Federal do Rio Grande do Norte, Brazil

Publisher

FapUNIFESP (SciELO)

Subject

Surgery

Link

http://www.scielo.br/scielo.php?script=sci_pdf&pid=S0102-86502023000100251&tlng=en

Reference21 articles.

1. The burdens of cancer therapy: Clinical and economic outcomes of chemotherapy-induced mucositis;Elting LS;Cancer,2003

2. Systematic review of agents for the management of cancer treatment-related gastrointestinal mucositis and clinical practice guidelines;Bowen JM;Support Care Cancer,2019

3. Health claims substantiation for probiotic and prebiotic products;Sanders ME;Gut Microbes,2011

4. Expert consensus document: The international scientific association for probiotics and prebiotics consensus statement on the scope and appropriate use of the term probiotic;Hill C;Nat Rev Gastroenterol Hepatol,2014

5. Bacteria-derived long chain fatty acid exhibits anti-inflammatory properties in colitis;Pujo J;Gut,2021